Immune tolerance in multiple sclerosis
- PMID: 21488900
- PMCID: PMC3088997
- DOI: 10.1111/j.1600-065X.2011.01016.x
Immune tolerance in multiple sclerosis
Abstract
Multiple sclerosis is believed to be mediated by T cells specific for myelin antigens that circulate harmlessly in the periphery of healthy individuals until they are erroneously activated by an environmental stimulus. Upon activation, the T cells enter the central nervous system and orchestrate an immune response against myelin. To understand the initial steps in the pathogenesis of multiple sclerosis, it is important to identify the mechanisms that maintain T-cell tolerance to myelin antigens and to understand how some myelin-specific T cells escape tolerance and what conditions lead to their activation. Central tolerance strongly shapes the peripheral repertoire of myelin-specific T cells, as most myelin-specific T cells are eliminated by clonal deletion in the thymus. Self-reactive T cells that escape central tolerance are generally capable only of low-avidity interactions with antigen-presenting cells. Despite the low avidity of these interactions, peripheral tolerance mechanisms are required to prevent spontaneous autoimmunity. Multiple peripheral tolerance mechanisms for myelin-specific T cells have been identified, the most important of which appears to be regulatory T cells. While most studies have focused on CD4(+) myelin-specific T cells, interesting differences in tolerance mechanisms and the conditions that abrogate these mechanisms have recently been described for CD8(+) myelin-specific T cells.
© 2011 John Wiley & Sons A/S.
Conflict of interest statement
The author declares no conflicts of interest.
Similar articles
-
Low avidity recognition of self-antigen by T cells permits escape from central tolerance.Immunity. 1995 Oct;3(4):407-15. doi: 10.1016/1074-7613(95)90170-1. Immunity. 1995. PMID: 7584132
-
Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au.Int Immunol. 2006 Jan;18(1):151-62. doi: 10.1093/intimm/dxh357. Epub 2005 Dec 16. Int Immunol. 2006. PMID: 16361316 Free PMC article.
-
A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis.J Exp Med. 2001 Sep 3;194(5):669-76. doi: 10.1084/jem.194.5.669. J Exp Med. 2001. PMID: 11535634 Free PMC article.
-
Immune tolerance to myelin proteins.Immunol Res. 2003;28(3):201-21. doi: 10.1385/IR:28:3:201. Immunol Res. 2003. PMID: 14713715 Review.
-
Mechanisms of central and peripheral T-cell tolerance: lessons from experimental models of multiple sclerosis.Immunol Rev. 1999 Jun;169:123-37. doi: 10.1111/j.1600-065x.1999.tb01311.x. Immunol Rev. 1999. PMID: 10450513 Review.
Cited by
-
Fungal infection in cerebrospinal fluid from some patients with multiple sclerosis.Eur J Clin Microbiol Infect Dis. 2013 Jun;32(6):795-801. doi: 10.1007/s10096-012-1810-8. Epub 2013 Jan 16. Eur J Clin Microbiol Infect Dis. 2013. PMID: 23322279
-
Members of the Regulatory Lymphocyte Club in Common Variable Immunodeficiency.Front Immunol. 2022 May 20;13:864307. doi: 10.3389/fimmu.2022.864307. eCollection 2022. Front Immunol. 2022. PMID: 35669770 Free PMC article. Review.
-
Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.PLoS One. 2014 Sep 3;9(9):e106335. doi: 10.1371/journal.pone.0106335. eCollection 2014. PLoS One. 2014. PMID: 25184418 Free PMC article.
-
An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS).Immun Ageing. 2021 Apr 14;18(1):18. doi: 10.1186/s12979-021-00225-0. Immun Ageing. 2021. PMID: 33853634 Free PMC article. Review.
-
Contributions of T cells in multiple sclerosis: what do we currently know?J Neurol. 2021 Dec;268(12):4587-4593. doi: 10.1007/s00415-020-10275-x. Epub 2020 Oct 20. J Neurol. 2021. PMID: 33083867 Review.
References
-
- Stromnes IM, Goverman JM. Active induction of experimental allergic encephalomyelitis. Nat Protocols. 2006;1:1810–9. - PubMed
-
- Raine C. The Lesion in Multiple Sclerosis and Chronic Relapsing Experimental Allergic Encephalomyelitis: A Structural Comparison. In: Raine CS, McFarland HF, Tourtellotte WW, editors. Multiple Sclerosis: Clinical and Pathogenetic Basis. London: Chapman and Hall; 1997. pp. 243–86.
-
- Goverman J, Perchellet A, Huseby ES. The role of CD8(+) T cells in multiple sclerosis and its animal models. Curr Drug Targets Inflamm Allergy. 2005;4:239–45. - PubMed
-
- Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain. 2005;128:1747–63. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials